The role of surgical margins in treatment of Ewing's sarcoma family tumors: Experience of a single institution with 512 patients treated with adjuvant and neoadjuvant chemotherapy

被引:73
|
作者
Bacci, G
Longhi, A
Briccoli, A
Bertoni, F
Versari, M
Picci, P
机构
[1] Ist Ortoped Rizzoli, Sect Chemotherapy, I-40136 Bologna, Italy
[2] Ist Ortoped Rizzoli, Thorac Surg Sect, I-40136 Bologna, Italy
[3] Ist Ortoped Rizzoli, Dept Musculoskeletal Oncol, Pathol Lab, I-40136 Bologna, Italy
[4] Ist Ortoped Rizzoli, Dept Musculoskeletal Oncol, Lab Oncol Res, I-40136 Bologna, Italy
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2006年 / 65卷 / 03期
关键词
Ewing's sarcoma; surgery; neoadjuvant chemotherapy; radiotherapy; extremity;
D O I
10.1016/j.ijrobp.2006.01.019
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the importance of surgical margins for local and systemic control of Ewing's sarcoma family tumors (ESFT). Methods and Materials: Between 1979 and 1999, 512 patients with ESFTs entered 4 different adjuvant and neoadjuvant studies performed at a single institution. Of these patients, 335 were treated with surgery alone (196) or surgery followed by radiotherapy at doses of 44.8 Gy (139). We compared their outcome with that of the 177 patients who were locally treated by radiotherapy at 60 Gy. Results: Local control (88.8% vs. 80.2%, p < 0.009) and 5-year disease-free survival (63.8% vs. 47.6%, p < 0.0007) were significantly better in patients treated with surgery and, among them, in those with adequate surgical margins (96.6 % vs. 71,7 %, p < 0.0008, and 69.6 % vs. 46.3 %, p < 0.0002). Nonetheless, better results were observed only in extremity tumors. Conclusions: Surgery is better than radiotherapy in cases of extremity ESFT with achievable adequate surgical margins, and in cases of inadequate surgical margins, adjuvant reduced-dose radiotherapy is ineffective. Therefore, when inadequate margins are expected, patients are better treated with full-dose radiotherapy from the start. (c) 2006 Elsevier Inc.
引用
收藏
页码:766 / 772
页数:7
相关论文
共 50 条
  • [31] Cyclophosphamide-hydroxycamptothecin as second-line chemotherapy for advanced Ewing's sarcoma: Experience of a single institution
    Han, Kun
    Sun, Yuanjue
    Zhang, Jianjun
    He, Aina
    Zheng, Shui'er
    Shen, Zan
    Yao, Yang
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (02) : E114 - E117
  • [32] Adjuvant and neoadjuvant chemotherapy for Ewing sarcoma family tumors in patients aged between 40 and 60 - Report of 35 cases and comparison of results with 586 younger patients treated with the same protocols in the same years
    Bacci, Gaetano
    Balladelli, Alba
    Forni, Cristiana
    Ferrari, Stefano
    Longhi, Alessandra
    Bacchini, Patrizia
    Alberghini, Marco
    Fabbri, Nicola
    Benassi, MariaSerena
    Briccoli, Antonio
    Picci, Piero
    CANCER, 2007, 109 (04) : 780 - 786
  • [33] Clinical outcomes and prognostic factors of adult's Ewing sarcoma family of tumors: single center experience
    Uyeturk, Ummugul
    Helvaci, Kaan
    Demirci, Ayse
    Sonmez, Ozlem Uysal
    Turker, Ibrahim
    Afsar, Cigdem Usul
    Budakoglu, Burcin
    Arslan, Ulku Yalcintas
    Oksuzoglu, Omur Berna
    Zengin, Nurullah
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2016, 20 (02): : 141 - 146
  • [34] Extraskeletal Ewing's Sarcoma Family of Tumours in Adults: Analysis of 57 Patients from a Single Institution
    El Weshi, A.
    Allam, A.
    Ajarim, D.
    Al Dayel, F.
    Pant, R.
    Bazarbashi, S.
    Memon, M.
    CLINICAL ONCOLOGY, 2010, 22 (05) : 374 - 381
  • [35] Imaging Features of Primary Tumors and Metastatic Patterns of the Extraskeletal Ewing Sarcoma Family of Tumors in Adults: A 17-Year Experience at a Single Institution
    Huh, Jimi
    Kim, Kyung Won
    Park, Seong Joon
    Kim, Hyoung Jung
    Lee, Jong Seok
    Ha, Hyun Kwon
    Tirumani, Harsha
    Ramaiya, Nikhil H.
    KOREAN JOURNAL OF RADIOLOGY, 2015, 16 (04) : 783 - 790
  • [36] Adjuvant and neo-adjuvant chemotherapy for Ewing's sarcoma family tumors and osteosarcoma of the extremity: further outcome for patients event-free survivors 5 years from the beginning of treatment
    Bacci, G.
    Balladelli, A.
    Forni, C.
    Ferrari, S.
    Longhi, A.
    Benassi, M. S.
    Briccoli, A.
    Serra, M.
    Picci, P.
    ANNALS OF ONCOLOGY, 2007, 18 (12) : 2037 - 2040
  • [37] Ewing Sarcoma family tumors of vertebral column treated with uniform chemotherapy protocols: Experience from a tertiary cancer care center
    Kumar, A.
    Biswas, B.
    Biswas, A.
    Bakhshi, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [38] High Dose Chemotherapy and Autologous Stem Cell Transplantation for Patients with High Risk or Relapsed Ewing Sarcoma Family of Tumors: A Single Institute Experience
    Hong, C. R.
    Kim, I. H.
    Park, S. H.
    Cheon, J. E.
    Kim, H. S.
    Kim, S. K.
    Kim, H. Y.
    Kang, C. H.
    Kang, H. J.
    Park, K. D.
    Shin, H. Y.
    Ahn, H. S.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S312 - S312
  • [39] High dose chemotherapy and autologous stem cell transplantation for patients with high risk or relapsed Ewing sarcoma family of tumors: a single institute experience
    Hong, C. R.
    Kang, H. J.
    Park, K. D.
    Shin, H. Y.
    Ahn, H. S.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S490 - S491
  • [40] Treatment Outcomes of Pediatric Patients with Ewing Sarcoma Treated According to Euro Ewing 99 Protocol in Romania Between 2005-2015: A Single-Institution Experience
    Olteanu, E. D.
    Pruteanu, D. P.
    Mihut, E.
    Cernea, D.
    Cosnarovici, R.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S300 - S300